FDA Approves First Oral Treatment for Postpartum Depression FDAgov

For Immediate Release: August 04, 2023 Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adult… [+3754 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *